A number of PPAR α/γ dual agonists have been recently developed and others are being evaluated for their effects on insulin resistance in animal models and in type 2 diabetes patients [11], [12], [13], [14], [15], [16]. The gene discussed is PPARA; the disease is type 2 diabetes mellitus.